Stomach-Stitching procedure could reverse scarring in deadly liver disease
NCT ID NCT04820036
Summary
This study is testing whether a minimally invasive stomach-shrinking procedure can treat advanced fatty liver disease (NASH) in people with obesity. Researchers will perform the endoscopic sleeve gastroplasty procedure on 20 participants and measure changes in liver scarring, fat, and pressure over 12 months. The goal is to see if this weight-loss procedure can improve or reverse liver damage caused by NASH.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.